Experimental infection with Vibrio salmonicida in atlantic salmon (Salmo salar L.): An evaluation of three different challenge methods

Aquaculture

Volumn 158, Issue 1-2, 1997, Pages 23-32

  Nordmo, R ^a   Sevatdal, S ^a   Ramstad, A ^a  

^a VESO Vikan AkvaVet   (Norway)

Author keywords

Atlantic salmon; Challenge; Vibrio salmonicida

Indexed keywords

EID: 0031446090     PISSN: 00448486     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0044-8486(97)00208-1     Document Type: Article

References (18)

1. Amend, D.F., 1981. Potency testing of fish vaccines. Dev. Biol. Standardization 49, 447-454.
2. Bruno, D.W., Hastings, T.S., Ellis, A.E., Wootten, R., 1985. Outbreak of cold water vibriosis in Atlantic salmon in Scotland. Bull. Eur. Assoc. Fish Pathol. 5, 62-63.
3. Bruno, D.W., Hastings, T.S., Ellis, A.E., 1986. Histopathology, bacteriology and experimental transmission of cold-water vibriosis in Atlantic salmon, Salmo salar. Dis. Aquatic Organisms 1, 163-168.
4. Cardella, M.A., Eimers, M.E., 1990. Safety and potency testing of federally licensed fish bacterins. J. Aquatic Animal Health 2, 49-55.
5. Cox, W.R., Rainnie, D.J., 1991. Oxytetracycline for the treatment of vibriosis in Atlantic salmon. Bull. Aquacult. Assoc. Canada 3, 50-52.
6. Egidius, E., Wiik, R., Andersen, K., Hoff, K.A., Hjeltnes, B., 1986. Vibrio salmonicida sp. nov., a new fish pathogen. Int. J. Syst. Bacteriol. 36, 518-520.
7. EU, Cump, 1993. Guidance for Vaccines Intended for Fish. Commission of the European Communities III/3590/92/EN, pp. 1-9.
8. Gjedrem, T., Gjøen, H.M., 1995. Genetic variation in susceptibility of Atlantic salmon, Salmo salar L., to furunculosis, BKD and cold water vibriosis. Aquacult. Res. 26, 129-134.
9. Hjeltnes, B., Roberts, R.J., 1993. Vibriosis. In: Inglis, V., Roberts, R.J., Bromage, N.R. (Eds.), Bacterial Diseases of Fish, Blackwell Scientific Public., Oxford, pp. 109-121.
10. Hjeltnes, B., Andersen, K., Ellingsen, H.M., Egidius, E., 1987. Experimental studies on the pathogenicity of a Vibrio sp. isolated from Atlantic salmon, Salmo salar L., suffering from Hitra disease. J. Fish Dis. 10, 21-27.
11. Ingram, G.A., 1980. Substances involved in the natural resistance of fish to infection - A review. J. Fish Biol. 16, 23-60.
12. Lillehaug, A., Sørum, H., Ramstad, A., 1990. Cross-protection after immunization of Atlantic salmon, Salmo salar L., against different strains of Vibrio salmonicida. J. Fish Dis. 13, 519-523.
13. Lillehaug, A., Ramstad, A., Bækken, K., Reitan, L.J., 1993. Protective immunity in Atlantic salmon (Salmo salar L.) vaccinated at different water temperatures. Fish Shellfish Immunol. 3, 143-156.
14. Nordmo, R., Ramstad, A., 1997. Comparison of different challenge methods to evaluate the efficacy of furunculosis vaccines in Atlantic salmon, Salmo salar L. J. Fish Dis. 20, 119-126.
15. Nordmo, R., Ramstad, A., Riseth, J.M.H., 1997. Induction of experimental furunculosis in heterogenous test populations of Atlantic salmon (Salmo salar L.) by use of a cohabitation method. Aquaculture (submitted).
16. Poppe, T.T., Håstein, T., Salte, R., 1985. 'Hitra disease' (haemorrhagic syndrome) in Norwegian salmon farming. In: Ellis, A.E. (Ed.), Fish and Shellfish Pathology, Academic Press, London, pp. 223-229.
17. Press, C.M., Lillehaug, A., 1995. Vaccination in European salmonid aquaculture: a review of practices and prospects. Br. Vet. J. 151, 45-69.
18. Sørum, H., Myhr, E., Zwicker, B.M., Lillehaug, A., 1993. Comparison by plasmid profiling of Vibrio salmonicida strains isolated from diseased fish from different north European and Canadian coastal areas of the Atlantic ocean. Can. J. Fisheries Aquatic Sci. 50, 247-250.